These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8488540)

  • 1. Effective use of a strategy using assigned red cell units to limit donor exposure for neonatal patients.
    Cook S; Gunter J; Wissel M
    Transfusion; 1993 May; 33(5):379-83. PubMed ID: 8488540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing blood donor exposure in the neonates by using dedicated donor transfusions.
    Jain R; Jarosz CR; Myers TF
    Transfus Sci; 1997 Jun; 18(2):199-203. PubMed ID: 10174685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel strategy to limit blood donor exposure and blood waste in multiply transfused premature infants.
    Wang-Rodriguez J; Mannino FL; Liu E; Lane TA
    Transfusion; 1996 Jan; 36(1):64-70. PubMed ID: 8607157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety.
    Strauss RG; Burmeister LF; Johnson K; James T; Miller J; Cordle DG; Bell EF; Ludwig GA
    Transfusion; 1996 Oct; 36(10):873-8. PubMed ID: 8863773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of a donor exposure reduction programme for multiple-transfused very-low-birth-weight infants.
    Kirsten GF; Kirsten CL; Faber M; Collett C; Mitchell CA; Bird AR
    S Afr Med J; 1996 Nov; 86(11 Suppl):1460-4. PubMed ID: 9180796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of donor exposures in premature infants by the use of designated adenine-saline preserved split red blood cell packs.
    Mangel J; Goldman M; Garcia C; Spurll G
    J Perinatol; 2001 Sep; 21(6):363-7. PubMed ID: 11593369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a limited-donor blood program for neonatal red cell transfusions.
    Hilsenrath P; Nemechek J; Widness JA; Cordle DG; Strauss RG
    Transfusion; 1999 Sep; 39(9):938-43. PubMed ID: 10533818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal transfusion models to determine the impact of using fresh red blood cells on inventory and exposure.
    Quinn K; Quinn M; Moreno C; Soundar E; Teruya J; Hui SK
    Blood Transfus; 2015 Oct; 13(4):595-9. PubMed ID: 26192783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing patterns of red blood cell transfusion in very low birth weight infants.
    Widness JA; Seward VJ; Kromer IJ; Burmeister LF; Bell EF; Strauss RG
    J Pediatr; 1996 Nov; 129(5):680-7. PubMed ID: 8917234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
    Rosenberg EM; Chambers LA; Gunter JM; Good JA
    Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high rate of blood donor exposure for critically ill neonates.
    Donowitz LG; Turner RB; Searcy MA; Luban NL; Hendley JO
    Infect Control Hosp Epidemiol; 1989 Nov; 10(11):509-10. PubMed ID: 2584678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial assessing the feasibility and safety of biologic parents as RBC donors for their preterm infants.
    Strauss RG; Burmeister LF; Johnson K; Cress G; Cordle DG
    Transfusion; 2000 Apr; 40(4):450-6. PubMed ID: 10773058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing donor exposure in preterm infants requiring multiple blood transfusions.
    Wood A; Wilson N; Skacel P; Thomas R; Tidmarsh E; Yale C; de Silva M
    Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F29-33. PubMed ID: 7743280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and safety of AS-3 red blood cells for neonatal transfusions.
    Strauss RG; Burmeister LF; Johnson K; Cress G; Cordle D
    J Pediatr; 2000 Feb; 136(2):215-9. PubMed ID: 10657828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a strategy to limit blood donor exposure in high risk premature newborns based on clinical estimation of transfusion need.
    van Straaten HL; de Wildt-Eggen J; Huisveld IA
    J Perinat Med; 2000; 28(2):122-8. PubMed ID: 10875097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants.
    Bianchi M; Giannantonio C; Spartano S; Fioretti M; Landini A; Molisso A; Tesfagabir GM; Tornesello A; Barbagallo O; Valentini CG; Vento G; Zini G; Romagnoli C; Papacci P; Teofili L
    Neonatology; 2015; 107(2):81-6. PubMed ID: 25401961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants.
    Madan A; Kumar R; Adams MM; Benitz WE; Geaghan SM; Widness JA
    J Perinatol; 2005 Jan; 25(1):21-5. PubMed ID: 15496875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloimmunization in preterm infants after repeated transfusions of WBC-reduced RBCs from the same donor.
    Strauss RG; Johnson K; Cress G; Cordle DG
    Transfusion; 2000 Dec; 40(12):1463-8. PubMed ID: 11134565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.